---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-038728"
form_type: "8-K"
ticker: "PDSB"
cik: "0001472091"
company_name: "PDS Biotechnology Corp"
filed_at: "2026-10-06T12:05:36+00:00"
generated_at: "2026-10-12T16:33:24.784966+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# PDS Biotech to Host Oct. 15 KOL Event on PDS0301 in Metastatic Colorectal Cancer

## Summary
- PDS Biotechnology (Nasdaq: PDSB) will host a virtual KOL event on October 15, 2026, at 8:00 AM ET featuring NCI/CCR investigator Jonathan M. Hernandez, M.D.
- Event covers clinical outcomes from PDS0301 Phase 2 trials in advanced liver-associated cancers, focusing on the metastatic colorectal cancer (mCRC) cohort.
- PDS0301 is an investigational IL-12 immunocytokine designed to bind necrotic DNA in tumors and deliver IL-12 to promote T cell and NK cell infiltration.
- Trial population includes second- and third-line unresectable microsatellite stable (MSS) or mismatch repair-proficient (pMMR) colorectal liver metastases, the majority of mCRC.

## SEC filing metadata
- accession: 0001140361-26-038728
- form_type: 8-K
- ticker: PDSB
- cik: 0001472091
- company_name: PDS Biotechnology Corp
- filed_at: 2026-10-06T12:05:36+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472091/000114036126038728/0001140361-26-038728-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472091/000114036126038728/ef20083341_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-038728
- JSON: https://secwatch.observer/filing/0001140361-26-038728.json
- Plain text: https://secwatch.observer/filing/0001140361-26-038728.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.